Use of remdesivir in kidney transplant recipients with SARS-CoV-2 Omicron infection.

MLA

Cacho, Judit, et al. “Use of Remdesivir in Kidney Transplant Recipients with SARS-CoV-2 Omicron Infection.” Kidney International, vol. 102, no. 4, Oct. 2022, pp. 917–21. EBSCOhost, https://doi.org/10.1016/j.kint.2022.08.001.

APA

Cacho, J., Nicolás, D., Bodro, M., Cuadrado-Payán, E., Torres-Jaramillo, V., Gonzalez-Rojas, Á., Ventura-Aguiar, P., Montagud-Marrahi, E., Herrera, S., Rico, V., Cofàn, F., Oppenheimer, F., Revuelta, I., Diekmann, F., & Cucchiari, D. (2022). Use of remdesivir in kidney transplant recipients with SARS-CoV-2 Omicron infection. Kidney International, 102(4), 917–921. https://doi.org/10.1016/j.kint.2022.08.001

Chicago

Cacho, Judit, David Nicolás, Marta Bodro, Elena Cuadrado-Payán, Verónica Torres-Jaramillo, Ángela Gonzalez-Rojas, Pedro Ventura-Aguiar, et al. 2022. “Use of Remdesivir in Kidney Transplant Recipients with SARS-CoV-2 Omicron Infection.” Kidney International 102 (4): 917–21. doi:10.1016/j.kint.2022.08.001.